Inhibikase Therapeutics (IKT): Number of Employees & Key Executives

15Current Employees▲ +7 (+87.50%) YoY

Source:10-Kfiled on 3/27/2025

Inhibikase Therapeutics total employee count in 2025 was 15, a +7 (+87.50%) increase in headcount from 2024.
Inhibikase Therapeutics total employee count in 2024 was 8, a +2 (+33.33%) increase in headcount from 2023.
Inhibikase Therapeutics total employee count in 2023 was 6, no year-over-year change in headcount. Revenue per employee was $63,990, a $53,687 (+521.08%) increase from 2022.
Inhibikase Therapeutics total employee count in 2022 was 6, a +3 (+100.00%) increase in headcount from 2021. Revenue per employee was $10,303, a -$1,255,407 (-99.19%) decline from 2021.

Company Executives

Current executive leadership team at Inhibikase Therapeutics (IKT)

Insider Trade History

Recent and historical insider trading activity at Inhibikase Therapeutics (IKT)

Back to Inhibikase Therapeutics (IKT) Financial Details Page